Status:
UNKNOWN
Alucent Vessel Restoration System for AVF
Lead Sponsor:
Alucent Biomedical
Conditions:
AV Fistula
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Feasibility of the Vessel Restoration System for AVF
Detailed Description
A study of the safety and feasibility of the Vessel Restoration System for AVF to promote the physiologic and functional maturation of a Brachiocephalic End-to-Side Arteriovenous Fistulas (AVF) in Pat...
Eligibility Criteria
Inclusion Criteria:
- 18 years of age and can provide informed consent
- Use birth control
- Chronic Kidney Disease
Exclusion Criteria:
- Receiving hemodialysis
- Pregnant, breastfeeding, planning to become pregnant
- Receiving immunosuppressants
- Has "Long COVID"
Key Trial Info
Start Date :
July 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 15 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05462223
Start Date
July 15 2022
End Date
December 15 2024
Last Update
March 13 2024
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia, 2050
2
Prince of Wales
Randwick, New South Wales, Australia, 2031
3
Royal North Shore Hospital & North Shore Private
Saint Leonards, New South Wales, Australia, 2065
4
Royal Adelaide Hospital
Adelaide, South Australia, Australia, 5000